# PSMA-PET to Guide Prostatectomy

Source: https://onco.cc/trials/nct05381103/  
OnCo record `nct05381103` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 2/3 trial of an investigational treatment in prostate cancer, run by Five Eleven Pharma, Inc., now recruiting.

## Summary

PSMA-PET to Guide Prostatectomy is a phase 2/3 interventional study registered as NCT05381103 by Five Eleven Pharma, Inc., with 288 participants planned, started 2021-10-01 and due to reach its primary completion in 2028-06-01.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-16
- Tags: pipeline; ctgov-ingest
- Registry id: NCT05381103
- Phase: 2/3
- Setting: PSMA-PET to Guide Prostatectomy: A Randomized Trial
- Sponsor: Five Eleven Pharma, Inc.
- Enrolled: 288

## Sources

- ClinicalTrials.gov NCT05381103: https://clinicaltrials.gov/study/NCT05381103

## Connected records

- cancers: [Prostate cancer](https://onco.cc/cancers/prostate/)

---
JSON: https://onco.cc/api/v1/entities/nct05381103.json